His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.
A Big Pharma giant quietly bought one AI-designed drug for $4 billion designed by a tiny AI-biotech company. Wall Street doesn't yet grasp how this company is quietly revolutionizing the drug discovery business but this won't stay quiet much longer.
On September 2022, crypto millionaire James Altucher published a video saying he had sold all his Bitcoin... and doubled down on this crypto instead. At the time, cryptos had already dropped 70%. But James still said this crypto was a good investment. Was he right? Or did he embarrass himself?
"Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August... To become the next President of the United States. When you see who, you'll be terrified... Because if I'm right about the election outcome... I'm recommending every American make urgent moves with their money right now." --Louis Navellier
I urge you to check it out before we take the video down. You'll discover how AI discovered a new treatment in only 30 days, why Big Pharma signed over $3 billion in deals with one AI-biotech, and why Bill Gates and billionaire Steve Cohen own over 10% of this company.
It could usher in the most radical transformation of our money we've ever seen in America's history... trigger a surprise election outcome in the coming months... and fundamentally alter the value of your savings forever. One 24-year market veteran warns that most Americans simply aren't prepared for what's coming on May 1.